RAPID ACCESS TO INTERVENTION DEVELOPMENT (RAID)

RELEASE DATE:  June 7, 2004

NOTICE:  NOT-CA-04-019

National Cancer Institute (NCI)
 (http://www.nci.nih.gov)

The NATIONAL CANCER INSTITUTE (NCI) is requesting applications for the following 
initiative: Rapid Access to Intervention Development (RAID).  RAID will make 
available to academic investigators, on a competitive basis, the preclinical 
development contract resources of NCI’s Developmental Therapeutics Program 
(DTP).  RAID is not a grant program.  Approved applications to RAID instead gain 
access to the drug development contract resources of the Developmental 
Therapeutics Program.  The goal of RAID is the rapid movement of novel molecules 
and concepts from the laboratory to the clinic for proof-of-principle clinical 
trials.  RAID will assist investigators who submit successful applications by 
providing any (or all) of the preclinical development steps that may be 
obstacles to clinical translation.  Possible tasks may include production, bulk 
supply, good manufacturing process (GMP) manufacturing, formulation, and 
toxicology.  Suitable agents for RAID will include small molecules, biologics, 
or vaccines.  

There are two receipt dates, February 1 and August 1, for requests for RAID 
support per year.  Current requests must be received by August 1, 2004, with all 
materials submitted directly to the office listed below.   

For information on the procedure for requesting RAID resources, visit the DTP 
web site http://dtp.nci.nih.gov/.  Inquiries are encouraged and 
DTP staff welcomes opportunities to clarify issues or answer questions about the 
RAID program.  Academic investigators may have collaborations with small-business 
partners and still qualify for RAID funding.  Non-profit organizations other 
than universities may also submit RAID applications.  Please note that a maximum 
of two distinct requests for support per investigator can be submitted for each 
receipt date. 

INQUIRIES:

Inquiries regarding this notice may be directed to: 

RAID
Office of Associate Director
Developmental Therapeutics Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
6130 Executive Blvd., EPN Suite 8022
Bethesda, MD 20892 (U.S. mail)
Rockville, MD 20852 (for express/courier service)
Telephone: 301-496-8720
Fax: 301-402-0831
Email:  raid@dtpax2.ncifcrf.gov


Return to Volume Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.